Skip to main content
. Author manuscript; available in PMC: 2014 Feb 24.
Published in final edited form as: Pharmacogenet Genomics. 2010 Mar;20(3):187–194. doi: 10.1097/FPC.0b013e328336eefe

Table 1.

Baseline Characteristics of First Study Population

Characteristics Controls (n=557) Ischemic Stroke
Hemorrhage (n=221)
Total (n=558) LVD (n=410) Lacunar (n=148)
Age, y 62.2 ± 9.3 61.1 ± 9.5 60.0 ± 9.7* 64.2 ± 8.3* 57.7 ± 11.2*
Men, % 62.1 64.7 65.4 62.8 67.4
BMI, kg/m2 23.7 ± 3.2 24.5 ± 3.7* 24.4 ± 3.4* 24.7 ± 4.4* 23.7 ± 3.5
SBP, mm Hg 131.3 ± 20.8 146.6 ± 23.3* 147.1 ± 24.1* 145.0 ± 21.0* 153.5 ± 25.3*
DBP, mm Hg 78.8 ± 11.1 86.4 ± 13.9* 87.0 ± 14.2* 84.9 ± 12.9* 93.3 ± 16.9*
HDL-C, mmol/L 1.33 ± 0.36 1.04 ± 0.54* 0.99 ± 0.30* 1.16 ± 0.91* 1.05 ± 0.40*
TC, mmol/L 4.56 ± 1.70 4.57 ± 1.13* 4.57 ± 1.13* 4.57 ± 1.12* 4.34 ± 1.07*
Hypertension, % 19.2 69.7* 69.0* 71.6* 65.2*
Diabetes, % 3.2 17.9* 19.8* 12.8* 4.1
Hyperlipidemia, % 21.0 35.0* 35.4* 33.8* 11.3*
Smokers, % 37.3 46.9* 45.8* 50.0* 47.1*

Mean ± standard deviation; BMI indicates body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol.

*

p<0.01 vs control.